Search hospitals

>

Texas

>

Fort Worth

Cook Children's Medical Center

Claim this profile

Fort Worth, Texas 76104

Global Leader in Neuroblastoma

Global Leader in Cancer

Conducts research for Leukemia

Conducts research for Brain Tumor

Conducts research for Acute Lymphoblastic Leukemia

488 reported clinical trials

18 medical researchers

Photo of Cook Children's Medical Center in Fort WorthPhoto of Cook Children's Medical Center in Fort WorthPhoto of Cook Children's Medical Center in Fort Worth

Summary

Cook Children's Medical Center is a medical facility located in Fort Worth, Texas. This center is recognized for care of Neuroblastoma, Cancer, Leukemia, Brain Tumor, Acute Lymphoblastic Leukemia and other specialties. Cook Children's Medical Center is involved with conducting 488 clinical trials across 622 conditions. There are 18 research doctors associated with this hospital, such as Kelly L. Vallance, Kenneth M. Heym, Sibo Zhao, MD, and Mary Meaghan P. Granger.

Area of expertise

1

Neuroblastoma

Global Leader

Cook Children's Medical Center has run 79 trials for Neuroblastoma. Some of their research focus areas include:

MYC positive
Stage IV
ROS1 positive
2

Cancer

Global Leader

Cook Children's Medical Center has run 69 trials for Cancer. Some of their research focus areas include:

Stage IV
Stage I
Stage II

Top PIs

Clinical Trials running at Cook Children's Medical Center

Cancer

Leukemia

Testicular cancer

Neuroblastoma

Acute Lymphoblastic Leukemia

Wilms Tumor

Cystic Fibrosis

Burkitt Lymphoma

Crohn's Disease

Acute Leukemia

Image of trial facility.

Chemotherapy

for Cancer

This phase III trial studies how well active surveillance help doctors to monitor subjects with low risk germ cell tumors for recurrence after their tumor is removed. When the germ cell tumor has spread outside of the organ in which it developed, it is considered metastatic. Chemotherapy drugs, such as bleomycin, carboplatin, etoposide, and cisplatin, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. The trial studies whether carboplatin or cisplatin is the preferred chemotherapy to use in treating metastatic standard risk germ cell tumors.

Recruiting

2 awards

Phase 3

26 criteria

Image of trial facility.

Triptorelin

for Cancer

This phase III trial compares the effect of giving triptorelin vs no triptorelin in preventing ovarian damage in adolescents and young adults (AYAs) with cancer receiving chemotherapy with an alkylating agents. Alkylating agents are part of standard chemotherapy, but may cause damage to the ovaries. If the ovaries are not working well or completely shut down, then it will be difficult or impossible to get pregnant in the future. Triptorelin works by blocking certain hormones and causing the ovaries to slow down or pause normal activity. The triptorelin used in this study stays active in the body for 24 weeks or about 6 months after a dose is given. After triptorelin is cleared from the body, the ovaries resume normal activities. Adding triptorelin before the start of chemotherapy treatment may reduce the chances of damage to the ovaries.

Recruiting

2 awards

Phase 3

4 criteria

Image of trial facility.

Cord Blood Units

for Blood Cancers

This study is an access and distribution protocol for unlicensed cryopreserved cord blood units (CBUs) in pediatric and adult patients with hematologic malignancies and other indications.

Recruiting

1 award

N/A

3 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at Cook Children's Medical Center?

Where is Cook Children's Medical Center located?

Who should I call to ask about financial aid or insurance network?

What insurance does Cook Children's Medical Center accept?

What awards or recognition has Cook Children's Medical Center received?